Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Search results (632)

« Back to Publications

Molnupiravir Treatment for COVID-19 in People at Higher Risk in the Community: Outcomes from the PANORAMIC Randomised Controlled Trial at Three and Six Months

Harris V. et al, (2026)

The impact of recurrent urinary tract infections in women: a qualitative study.

Glogowska M. et al, (2026), Br J Gen Pract

Economic Evaluation of Oral Nirmatrelvir-Ritonavir for COVID-19 in Higher Risk Outpatients

Png ME. et al, (2026), JAMA Network Open, 9

Economic Evaluation of Oral Nirmatrelvir-Ritonavir for COVID-19 in Higher Risk Outpatients

Png ME. et al, (2026), JAMA Network Open, 9, e2612381 - e2612381

Explaining variation in antibiotic prescribing for common infections: a three-way variance decomposition using UK primary care data

Nguyen NV. et al, (2026)

Nirmatrelvir–ritonavir versus usual care in at-risk adults with early SARS-CoV-2 infection in the UK, 2022–23: virological and immunological results of an open-label randomised trial (PANORAMIC)

Lowe DM. et al, (2026), Lancet Microbe, 7

Oral Nirmatrelvir-Ritonavir for Covid-19 in Higher-Risk Outpatients

Butler CC. et al, (2026), New England Journal of Medicine, 394, 1583 - 1594

Clean pulp versus sterile plastic for mid-stream urine collection: a paired equivalence study comparing the microbiological performance of a novel low carbon collection device with the standard of care.

John JB. et al, (2026), BMJ Open, 16

Association between pharmacological tenofovir adherence measures and subsequent 24-week viral load outcomes for people with HIV in South Africa.

Bodley N. et al, (2026), J Acquir Immune Defic Syndr

Nasal sprays and a behavioural intervention for respiratory tract infections in primary care: 12-month follow-up of a randomised open-label trial.

Little P. et al, (2026), Br J Gen Pract

Point-of-care HIV viral load testing in a community antiretroviral therapy delivery programme: A randomised controlled trial (PHILA)

Dorward J. et al, (2026), Plos Global Public Health, 6

Defining recurrent urinary tract infection and reinfection risk: electronic health record study.

Vazquez-Montes MD. et al, (2026), BJGP Open

Point-of-care testing strategy versus usual care to safely reduce antibiotic prescribing for acute respiratory tract infections in primary care (PRUDENCE): a pragmatic, randomised controlled trial in 13 countries

van der Velden AW. et al, (2026), The Lancet Primary Care, 2, 100104 - 100104

Clinician and patient experiences with point-of-care testing for acute respiratory infections in primary care: a qualitative process evaluation of the PRUDENCE trial

Wanat M. et al, (2026), The Lancet Primary Care, 2

Obesity in Recovery From Influenza-Like Illness and Effectiveness of Oseltamivir

Nguyen O. et al, (2025), Influenza and Other Respiratory Viruses, 19

Load More

1
2
3
4
5
6
7
...
»